Page last updated: 2024-11-05

tropicamide and Obesity

tropicamide has been researched along with Obesity in 1 studies

Tropicamide: One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
"Tropicamide and atropine were used to deepen the anterior chamber."1.34Anorexiant-induced transient myopia after myopic laser in situ keratomileusis. ( Chang, JH; Chung, JK; Lee, W; Ohn, YH; Roh, KH, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, W1
Chang, JH1
Roh, KH1
Chung, JK1
Ohn, YH1

Other Studies

1 other study available for tropicamide and Obesity

ArticleYear
Anorexiant-induced transient myopia after myopic laser in situ keratomileusis.
    Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:4

    Topics: Adult; Appetite Depressants; Atropine; Choroid; Ciliary Body; Humans; Keratomileusis, Laser In Situ;

2007